(Q44576306)
Statements
1 reference
The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically (English)
1 reference
1 reference
1 reference
Angela Garofalo
1 reference
Elitza Naumova
1 reference
Luigi Manenti
1 reference
Gabriele Ghisleni
1 reference
Mario Caniatti
1 reference
Tina Colombo
1 reference
Julie M Cherrington
1 reference
Eugenio Scanziani
1 reference
Maria Ines Nicoletti
1 reference
1 August 2003
1 reference
1 reference